UCSF Medical Center Antimicrobial Susceptibility: Pseudomonas aeruginosa 2014

PrintPrintPDFPDF

The table below details the percent susceptibility of inpatient isolates of Pseudomonas aeruginosa to single agents and to the combination of antimicrobials indicated (number to the right of the arrow).  Excludes cystic fibrosis isolates.  Data are from 2014.

 MER=meropenem; TOB=tobramycin; PIPTAZ=piperacillin/tazobactam; CFPM=cefepime; CIP=ciprofloxacin

 

MER -->

MER+TOB

PIPTAZ -->

PIPTAZ+TOB

CFPM -->

CFPM+TOB

MER --> MER+CIP

PIPTAZ  -->

PIPTAZ+CIP

CFPM -->

CFPM+CIP

All Patients

82%--> 97%

86% --> 97%

88% --> 98%

82% --> 91%

86% --> 94%

88% --> 93%

ICU

79% --> 100%

88% --> 98%

78% --> 98%

79% --> 95%

88% --> 95%

78% --> 95%

Floor

82% --> 97%

86% --> 98%

90% --> 98%

82% --> 90%

86% --> 94%

88% --> 92%